Alector, Inc. Earnings Per Share (Basic)
Alector, Inc. (ALEC) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Alector, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.21.
- Alector, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.21.
- Alector, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.34.
- Alector, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.34.
- Alector, Inc. earnings per share, basic for fiscal 2025 was -$1.39.
- Alector, Inc. earnings per share, basic for fiscal 2024 was -$1.23.
- Alector, Inc. earnings per share, basic for fiscal 2023 was -$1.56.
- Alector, Inc. earnings per share, basic for fiscal 2022 was -$1.62.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-06 | -$0.41 10-Q · filed 2026-08-06 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.21 10-Q · filed 2026-05-07 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.39 10-K · filed 2026-02-25 |
| 2025-09-30 | -$0.34 10-Q · filed 2025-11-06 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.05 10-Q · filed 2025-11-06 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.30 10-Q · filed 2026-08-06 | -$0.71 10-Q · filed 2026-08-06 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.41 10-Q · filed 2026-05-07 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.23 10-K · filed 2026-02-25 |
| 2024-09-30 | -$0.43 10-Q · filed 2025-11-06 | -$0.83 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.22 10-Q · filed 2025-11-06 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-06-30 | -$0.40 10-Q · filed 2025-08-07 | -$0.78 10-Q · filed 2025-08-07 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.79 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-03-31 | -$0.38 10-Q · filed 2025-05-08 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.56 10-K · filed 2025-02-26 |
| 2023-09-30 | -$0.53 10-Q · filed 2024-11-06 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$1.07 10-Q · filed 2024-11-06 | -$1.70 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2023-06-30 | $0.02 10-Q · filed 2024-08-07 | -$0.53 10-Q · filed 2024-08-07 | -$1.17 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.72 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2023-03-31 | -$0.55 10-Q · filed 2024-05-08 | -$1.19 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.74 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.63 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2022-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.19 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.07 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.62 10-K · filed 2025-02-26 |
| 2022-09-30 | -$0.56 10-Q · filed 2023-11-07 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.98 10-Q · filed 2023-11-07 | -$1.66 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-06-30 | $0.12 10-Q · filed 2023-08-03 | -$0.42 10-Q · filed 2023-08-03 | -$1.10 derived: net income ÷ weighted average shares · filed 2024-02-27 | $0.44 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-03-31 | -$0.54 10-Q · filed 2023-05-04 | -$1.23 derived: net income ÷ weighted average shares · filed 2024-02-27 | $0.32 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2024-02-27 | $0.87 derived: net income ÷ weighted average shares · filed 2024-02-27 | $0.20 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.45 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.56 10-Q · filed 2022-11-08 | $0.89 derived: net income ÷ weighted average shares · filed 2022-11-08 | $0.24 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$0.69 10-Q · filed 2022-08-04 | -$1.35 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.33 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.45 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$0.67 10-Q · filed 2021-11-04 | -$1.78 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |